A multi-treatment two stage adaptive allocation for survival outcomes
From MaRDI portal
Publication:5078392
DOI10.1080/03610926.2018.1440599OpenAlexW2793852761WikidataQ130172139 ScholiaQ130172139MaRDI QIDQ5078392
Rahul Bhattacharya, Madhumita Shome
Publication date: 23 May 2022
Published in: Communications in Statistics - Theory and Methods (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/03610926.2018.1440599
Related Items (1)
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- A Bayesian adaptive design for two-stage clinical trials with survival data
- A randomized two stage allocation for continuous response clinical trials
- Sequential estimation for two-stage and three-stage clinical trials
- Bioequivalence trials, intersection-union tests and equivalence confidence sets. With comments and a rejoinder by the authors
- Multiple Comparisons
- Constrained Statistical Inference
- A Bayesian model for time-to-event data with informative censoring
- Regression Survival Analysis with an Assumed Copula for Dependent Censoring: A Sensitivity Analysis Approach
- Some results on estimation for two—stage clinical trials
- On an ethical cum optimal adaptive allocation design
This page was built for publication: A multi-treatment two stage adaptive allocation for survival outcomes